Status:
ACTIVE_NOT_RECRUITING
Neuropsychological and Electrophysiological Effects of Dance Therapy With People With Severe Mental Disorders
Lead Sponsor:
Asociación Canaria de Terapias Creativas (ASCATEC)
Conditions:
Severe Mental Disorder
Eligibility:
All Genders
18-75 years
Phase:
NA
Brief Summary
A single-centre prospective randomised controlled trial will be conducted with a minimum of 47 patients with severe mental disorder (SMD) who will be randomly assigned into two groups, 1 intervention ...
Detailed Description
All the tests (BASC, MoCA, PANSS and EEG) will be carried out with the 47 patients with SMD to find out their baseline status. The people with SMD will be randomly assigned to an experimental group (d...
Eligibility Criteria
Inclusion
- Persons diagnosed with a serious mental disorder according to the Diagnostic and Statistical Manual of Mental Disorders -V.
- Have the capacity to decide and consent.
- Be between 18 and 75 years of age.
- No active consumption of toxic substances (except nicotine).
- Commitment to attend for the entire study period from December 2023 to December 2024.
Exclusion
- Not having given free consent to participate in the study.
- Having a comorbid severe mental disorder, associated intellectual disability, history of severe brain damage or neurological disorder that may function as a confounding factor (Associated organic-type disorder, borderline or lower IQ)
- Active substance abuse (except nicotine)
- Having a cochlear implant, fixed hearing aids or plates in the head.
- Having suffered a concussion to the head with loss of consciousness that subsequently triggered symptoms related to the pathology.
- Having suffered from epileptic seizures.
- Not having the desire to participate in dance therapy sessions for any reason or to undergo electroencephalogram testing.
- Currently involved and participating in another cognitive rehabilitation program.
Key Trial Info
Start Date :
September 12 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 30 2024
Estimated Enrollment :
47 Patients enrolled
Trial Details
Trial ID
NCT06219265
Start Date
September 12 2023
End Date
September 30 2024
Last Update
January 23 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
ASCATEC
Santa Cruz de Tenerife, Canary Islands, Spain, 38003